|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology, University College London, Medical Sciences Building, Gower Street, London WC1E 6BT, UK
Regulation of GABAA receptors by extracellular pH exhibits a dependence on the receptor subunit composition. To date, the molecular mechanism responsible for the modulation of GABAA receptors at alkaline pH has remained elusive. We report here that the GABA-activated current can be potentiated at pH 8.4 for both
ß and
ß
subunit-containing receptors, but only at GABA concentrations below the EC40. Site-specific mutagenesis revealed that a single lysine residue, K279 in the ß subunit TM2TM3 linker, was critically important for alkaline pH to modulate the function of both
1ß2 and
1ß2
2 receptors. The ability of low concentrations of GABA to reveal different pH titration profiles for GABAA receptors was also examined at acidic pH. At pH 6.4, GABA activation of
ß
receptors was enhanced at low GABA concentrations. This effect was ablated by the mutation H267A in the ß subunit. Decreasing the pH further to 5.4 inhibited GABA responses via
ß
receptors, whereas those responses recorded from
ß receptors were potentiated. Inserting homologous ß subunit residues into the
2 subunit to recreate, in
ß
receptors, the proton modulatory profile of
ß receptors, established that in the presence of ß2H267, the mutation
2T294K was necessary to potentiate the GABA response at pH 5.4. This residue, T294, is homologous to K279 in the ß subunit and suggests that a lysine at this position is an important residue for mediating the allosteric effects of both acidic and alkaline pH changes, rather than forming a direct site for protonation within the GABAA receptor.
(Received 18 April 2005;
accepted after revision 3 June 2005;
first published online 9 June 2005)
Corresponding author T.G. Smart: Department of Pharmacology, University College London, Medical Sciences Building, Gower Street, London WC1E 6BT, UK. Email: t.smart{at}ucl.ac.uk
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |